A prospective descriptive study of cryptococcal meningitis in HIV uninfected patients in Vietnam - high prevalence of Cryptococcus neoformans var grubii in the absence of underlying disease

[1]  J. Perfect,et al.  Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  P. Hsueh,et al.  Disseminated Cryptococcus neoformans var. grubii infections in intensive care units , 2009, Epidemiology and Infection.

[3]  S. Jaffar,et al.  Independent association between rate of clearance of infection and clinical outcome of HIV-associated cryptococcal meningitis: analysis of a combined cohort of 262 patients. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  T. Steiner,et al.  Dexamethasone in Cryptococcus gattii central nervous system infection. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  B. Wickes,et al.  Antifungal Susceptibilities among Different Serotypes of Cryptococcus gattii and Cryptococcus neoformans , 2008, Antimicrobial Agents and Chemotherapy.

[6]  A. Litvintseva,et al.  Cryptococcus neoformans Strains and Infection in Apparently Immunocompetent Patients, China , 2008, Emerging infectious diseases.

[7]  P. Hsueh,et al.  Disseminated cryptococcosis in HIV-uninfected patients , 2008, European Journal of Clinical Microbiology & Infectious Diseases.

[8]  S. Sungkanuparph,et al.  Comparison of clinical features and survival between cryptococcosis in human immunodeficiency virus (HIV)-positive and HIV-negative patients. , 2008, Japanese journal of infectious diseases.

[9]  J. Kronstad,et al.  The emergence of Cryptococcus gattii in British Columbia and the Pacific Northwest , 2008, Current infectious disease reports.

[10]  J. Heitman,et al.  First Contemporary Case of Human Infection with Cryptococcus gattii in Puget Sound: Evidence for Spread of the Vancouver Island Outbreak , 2007, Journal of Clinical Microbiology.

[11]  Y. Chow,et al.  Cryptococcus gattii Dispersal Mechanisms, British Columbia, Canada , 2007, Emerging infectious diseases.

[12]  K. Ng,et al.  In vitro susceptibilities of Malaysian clinical isolates of Cryptococcus neoformans var. grubii and Cryptococcus gattii to five antifungal drugs , 2006, Mycoses.

[13]  M. Pfaller,et al.  Global Trends in the Antifungal Susceptibility of Cryptococcus neoformans (1990 to 2004) , 2005, Journal of Clinical Microbiology.

[14]  T. Boekhout,et al.  A rare genotype of Cryptococcus gattii caused the cryptococcosis outbreak on Vancouver Island (British Columbia, Canada). , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[15]  M. Netea,et al.  Two patients with cryptococcal meningitis and idiopathic CD4 lymphopenia: defective cytokine production and reversal by recombinant interferon- gamma therapy. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[16]  J. Guarro,et al.  In Vitro Antifungal Susceptibility of Cryptococcus gattii , 2004, Journal of Clinical Microbiology.

[17]  L. Hoang,et al.  Cryptococcus neoformans infections at Vancouver Hospital and Health Sciences Centre (1997-2002): epidemiology, microbiology and histopathology. , 2004, Journal of medical microbiology.

[18]  N. White,et al.  Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial , 2004, The Lancet.

[19]  P. Kazembe,et al.  Antifungal Susceptibilities of Cryptococcus neoformans , 2004, Emerging infectious diseases.

[20]  W. Meyer,et al.  Molecular Typing of IberoAmerican Cryptococcus neoformans Isolates , 2003, Emerging infectious diseases.

[21]  C. Stephen,et al.  Multispecies outbreak of cryptococcosis on southern Vancouver Island, British Columbia. , 2002, The Canadian veterinary journal = La revue veterinaire canadienne.

[22]  R. M. Warren,et al.  Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[23]  E. Fung,et al.  Cryptococcosis: clinical and biological aspects. , 2000, Medical mycology.

[24]  K. Byth,et al.  Epidemiology and host- and variety-dependent characteristics of infection due to Cryptococcus neoformans in Australia and New Zealand. Australasian Cryptococcal Study Group. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[25]  Yee-Chun Chen,et al.  Cryptococcal meningitis in non-HIV-infected patients. , 2000, QJM : monthly journal of the Association of Physicians.

[26]  Y. C. Chen,et al.  Clinical features and in vitro susceptibilities of two varieties of Cryptococcus neoformans in Taiwan. , 2000, Diagnostic microbiology and infectious disease.

[27]  M. Saag,et al.  Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group. , 1997, The New England journal of medicine.

[28]  Y. Coovadia,et al.  Cryptococcal meningitis in Durban, South Africa: a comparison of clinical features, laboratory findings, and outcome for human immunodeficiency virus (HIV)-positive and HIV-negative patients. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[29]  L. Letenneur,et al.  Individual and environmental factors associated with infection due to Cryptococcus neoformans serotype D. French Cryptococcosis Study Group. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[30]  F. Dromer,et al.  Epidemiology of cryptococcosis in France: a 9-year survey (1985-1993). French Cryptococcosis Study Group. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[31]  D. Warrell,et al.  Predictors of outcome in Cryptococcus neoformans var. gattii meningitis. , 1996, QJM : monthly journal of the Association of Physicians.

[32]  L. Letenneur,et al.  Comparison of the efficacy of amphotericin B and fluconazole in the treatment of cryptococcosis in human immunodeficiency virus-negative patients: retrospective analysis of 83 cases. French Cryptococcosis Study Group. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[33]  D. Dunt,et al.  Clinical and host differences between infections with the two varieties of Cryptococcus neoformans. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[34]  T. Sorrell,et al.  Cryptococcal disease of the CNS in immunocompetent hosts: influence of cryptococcal variety on clinical manifestations and outcome. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[35]  J. Rex,et al.  Multicenter comparison of a colorimetric microdilution broth method with the reference macrodilution method for in vitro susceptibility testing of yeast isolates. , 1994, Diagnostic microbiology and infectious disease.

[36]  R. Rozenbaum,et al.  Clinical epidemiological study of 171 cases of cryptococcosis. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[37]  B. Currie,et al.  Cryptococcus neoformans in tropical northern Australia: predominantly variant gattii with good outcomes. , 1993, Australian and New Zealand journal of medicine.

[38]  R. Diasio,et al.  Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks. , 1987, The New England journal of medicine.

[39]  K. Kwon-Chung,et al.  Epidemiologic differences between the two varieties of Cryptococcus neoformans. , 1984, American journal of epidemiology.

[40]  K. Kwon-Chung,et al.  Epidemiologic differences among serotypes of Cryptococcus neoformans. , 1977, American journal of epidemiology.

[41]  J. Bennett,et al.  Prognostic factors in cryptococcal meningitis. A study in 111 cases. , 1974, Annals of internal medicine.

[42]  C. Stephen,et al.  Cryptococcus gattii in Wildlife of Vancouver Island, British Columbia, Canada , 2006, Journal of wildlife diseases.

[43]  S. Kiertiburanakul,et al.  Cryptococcosis in human immunodeficiency virus-negative patients. , 2006, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[44]  D. Denning,et al.  Cryptococcal meningitis in the immunocompromised host: intracranial hypertension and other complications , 2004, Mycopathologia.

[45]  D. Warrell,et al.  Visual loss in immunocompetent patients with Cryptococcus neoformans var. gattii meningitis. , 1997, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[46]  D. Warrell,et al.  The effect of corticosteroids on visual loss in Cryptococcus neoformans var. gattii meningitis. , 1997, Transactions of the Royal Society of Tropical Medicine and Hygiene.